Literature DB >> 8752099

2',3'-Cyclic nucleotide 3'-phosphodiesterase binds to actin-based cytoskeletal elements in an isoprenylation-independent manner.

D A De Angelis1, P E Braun.   

Abstract

2',3'-Cyclic nucleotide 3'-phosphodiesterase (CNP) is an isoprenylated protein enriched in myelin and oligodendrocytes but also present in several other tissues at low levels. CNP binds avidly to membranes and in addition possesses several characteristics of cytoskeletal proteins. The role of isoprenylation in the association of CNP with the cytoskeleton was analyzed by ectopic expression in L cells of epitope-tagged CNP1 and a non-isoprenylated mutant CNP1. Using nonionic detergent extraction, drug-mediated cytoskeletal disruption, and coimmunoprecipitation with an anti-actin antibody, we show that CNP1 is associated with actin-based cytoskeletal elements independently of its isoprenylation status. A control protein, p21c-H-ras, which is also modified by isoprenylation at its carboxyl-terminus, does not bind to cytoskeletal structures as judged by the same criteria. We present a model that accounts for the association of CNP1 with membranes and the cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752099     DOI: 10.1046/j.1471-4159.1996.67030943.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

Review 1.  The structure and function of myelin: from inert membrane to perfusion pump.

Authors:  Charissa A Dyer
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 2.  Alterations in gene expression associated with primary demyelination and remyelination in the peripheral nervous system.

Authors:  A D Toews; J Hostettler; C Barrett; P Morell
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 3.  The myelin membrane-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: on a highway to structure and function.

Authors:  Arne Raasakka; Petri Kursula
Journal:  Neurosci Bull       Date:  2014-05-07       Impact factor: 5.203

4.  Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis.

Authors:  M J Walsh; J M Murray
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

5.  Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes.

Authors:  C B Marta; C M Taylor; S Cheng; R H Quarles; R Bansal; S E Pfeiffer
Journal:  Neuron Glia Biol       Date:  2004-02

6.  Juxtanodin: an oligodendroglial protein that promotes cellular arborization and 2',3'-cyclic nucleotide-3'-phosphodiesterase trafficking.

Authors:  Bin Zhang; Qiong Cao; Anchen Guo; Haiying Chu; Yee Gek Chan; Jan Paul Buschdorf; Boon Chuan Low; Eng Ang Ling; Fengyi Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

Review 7.  Analogous structural motifs in myelin basic protein and in MARCKS.

Authors:  G Harauz; N Ishiyama; I R Bates
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

8.  A myelin gene causative of a catatonia-depression syndrome upon aging.

Authors:  Nora Hagemeyer; Sandra Goebbels; Sergi Papiol; Anne Kästner; Sabine Hofer; Martin Begemann; Ulrike C Gerwig; Susann Boretius; Georg L Wieser; Anja Ronnenberg; Artem Gurvich; Stephan H Heckers; Jens Frahm; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  EMBO Mol Med       Date:  2012-04-04       Impact factor: 12.137

9.  Myelin 2',3'-cyclic nucleotide 3'-phosphodiesterase: active-site ligand binding and molecular conformation.

Authors:  Matti Myllykoski; Arne Raasakka; Huijong Han; Petri Kursula
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 10.  The multiple roles of myelin protein genes during the development of the oligodendrocyte.

Authors:  Daniel Fulton; Pablo M Paez; Anthony T Campagnoni
Journal:  ASN Neuro       Date:  2010-02-01       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.